Leveraging RWD to Support Drug Assay Development in Molecular Oncology

Sponsored content for QIAGEN by BioPharma Dive's Brand Studio

WEBINAR ON-DEMAND
Duration: 1 hour

‚Äč
Although precision oncology has made rapid progress over the past few years, many questions remain. What answers lie in our DNA, and how can drug developers use that information to develop clinical trial protocols?

Join us to discuss the impact of real-world data on molecular oncology. This webinar will cover:

  • How customers can leverage real-world data in clinical and scientific settings.
  • Tips for using data to support biomarker selection decisions for diagnostic assays
  • Real world examples and case studies
     

SPEAKER

Sheryl Krevsky Elkin, PhD
Chief Scientific Officer
N-of-One, a QIAGEN company

WATCH NOW

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2019 Industry Dive